Status:
UNKNOWN
Intracorporeal Anastomosis in Laparoscopic Left Colectomy. Cohort Comparative Study
Lead Sponsor:
Corporacion Parc Tauli
Collaborating Sponsors:
Irene Gómez Torres
Laura Mora López
Conditions:
Colon Cancer
Eligibility:
All Genders
18+ years
Brief Summary
OBJECTIVE: The aim of the study is to demonstrate that the intracorporeal resection and anastomosis in left-sided colon cancer, sigma and upper rectum, is not inferior to extracoprporeal resection and...
Detailed Description
HYPOTHESIS Resection of the left colon / sigmoid with intracorporeal colorectal TT anastomosis is safe and not inferior to that performed extracorporeally. With the benefits of reduced intraoperative ...
Eligibility Criteria
Inclusion
- Left Colonic Adenocarcinoma. Location of the tumor in the left colon, sigma or high rectum (with the anastomosis performed above the peritoneal reflection). Non-metastatic stage. Scheduled oncological surgery with curative intention operated on with laparoscopic surgery with resection technique and intracorporeal anastomosis. Over 18 years
Exclusion
- Other tumor locations. Non-adenocarcinoma tumors. Synchronous tumors. T4 tumor stage and stage IV of TNM classification. ASA IV (American Society of Anesthesiologists). Non-optimal nutritional study (preoperative albumin ≤3.4 g / dl). Do not sign informed consent. Pregnant patients. Diagnosis of another type of neoplasm with active disease. Liver cirrhosis, Chronic kidney failure on dialysis treatment, patients with stent bridge to elective surgery.
Key Trial Info
Start Date :
June 29 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2022
Estimated Enrollment :
148 Patients enrolled
Trial Details
Trial ID
NCT04456933
Start Date
June 29 2020
End Date
February 28 2022
Last Update
November 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Parc Tauli de Sabadel
Sabadell, Barceelona, Spain, 08208